First open-label, randomized, crossover, inpatient pharmacokinetic phase I study of Naloxone (Intranasal and Intramuscular) in healthy adult volunteers.
Phase of Trial: Phase I
Latest Information Update: 27 Mar 2017
Price : $35 *
At a glance
- Drugs Naloxone (Primary) ; Naloxone (Primary)
- Indications Cocaine abuse; Eating disorders; Opioid abuse; Substance-related disorders
- Focus Adverse reactions; Pharmacokinetics
- 27 Mar 2017 Results published in an Opiant Pharmaceuticals media release.
- 08 Sep 2014 New trial record